DreamCIS, Inc. (KOSDAQ:223250)

Market Cap	74.73B
Revenue (ttm)	56.88B
Net Income (ttm)	4.67B
Shares Out	23.80M
EPS (ttm)	193.86
PE Ratio	16.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,576
Average Volume	105,553
Open	3,140.00
Previous Close	3,145.00
Day's Range	3,105.00 - 3,180.00
52-Week Range	2,610.00 - 5,390.00
Beta	0.28
RSI	57.84
Earnings Date	Mar 18, 2025

About DreamCIS

DreamCIS, Inc. provides clinical research services in South Korea. It offers clinical development services; biostatic, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea.

• Industry: Commercial Physical and Biological Research
• Founded: 2000
• Employees: 366
• Stock Exchange: KOSDAQ
• Ticker Symbol: 223250

Financial Performance

In 2023, DreamCIS's revenue was 47.84 billion, an increase of 23.08% compared to the previous year's 38.87 billion. Earnings were 3.74 billion, a decrease of -15.13%.